Internal Medicine, Rheumatology · Valparaiso, IN
NPI
1306161955
Since 2010
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
1461 Morthland Dr Ste A
Valparaiso, IN, 46385
Phone (219) 947-6713
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,193
67 services
Medicare patients, 2024
29
Average age 74
Drug cost, 2024
$5.9M
3,774 prescriptions
Company payments, 2025
$1,281
From 10 companies
Medicare prescription drug claims, 2024
In 2024, the drug Kirk Jenkins prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 813 prescriptions and refills. In total Kirk Jenkins wrote 3,774 Medicare prescriptions that cost $5.9M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-31.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Hydroxychloroquine Sulfate Generic | 813 | 2,221 | 230 | $34K |
| Methotrexate Methotrexate Sodium | 588 | 1,550 | 176 | $14K |
| Prednisone Generic | 344 | 486 | 103 | $2,659 |
| Allopurinol Generic | 198 | 565 | 48 | $1,682 |
| Rinvoq Upadacitinib | 180 | 200 | 24 | $1.3M |
| Enbrel Sureclick Etanercept | 159 | 162 | 17 | $1.2M |
| Leflunomide Generic | 138 | 350 | 37 | $9,316 |
| Gabapentin Generic | 102 | 172 | 20 | $1,291 |
| Folic Acid Generic | 90 | 275 | 30 | $1,138 |
| Methylprednisolone Generic | 83 | 90 | 30 | $646 |
| Humira(Cf) Pen Adalimumab | 82 | 91 | 11 | $713K |
| Sulfasalazine Generic | 77 | 167 | 19 | $1,490 |
| Otezla Apremilast | 71 | 71 | Under 11 | $351K |
| Amitriptyline Hcl Generic | 62 | 128 | 14 | $685 |
| Meloxicam Generic | 61 | 81 | 17 | $269 |
Brand drugs: - claims; generic drugs: 2,924 claims; opioid claims: 52.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kirk Jenkins $1,281 ($1,281 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $633.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 40 | $633 |
| Janssen Biotech, Inc. JNJ | 4 | $190 |
| Amgen Inc. AMGN | 13 | $164 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $80.57 |
| UCB, Inc. UCB.BR | 3 | $74.55 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $56.76 |
| Sobi, Inc SOBI.ST | 1 | $24.53 |
| Genentech USA, Inc. ROG.SW | 1 | $22.26 |
| Radius Health, Inc. | 1 | $19.45 |
| GlaxoSmithKline, LLC. GSK | 1 | $15.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.